Category Archives: Capital allocation

My 22 (+1) investments for 2019

Posted on by 4 comments

Edit: I actually forgot to include Expedia…..

This post has become now a small tradition at the end of December and is also very helpful for me to review my holdings.

The summaries of the previous years can be found here:

My 21 investments for 2018
My 27 investments for 2017
My 27 investments for 2016
My 28 investments for 2015
My 24 investments for 2014
My 22 investments for 2013

From the 21 stocks of last year, 4 have left the portfolio:

Silver Chef and Metro were clear mistakes from my side and I exited them as discussed with significant losses. IGE & XAO was a much more positive case. The company received a buy-out offer from Schneider SA and I exited at 138 EUR per share. DOM Security finally was merged into the main shareholder company SFPI. Luckily, I could sell 40% of my holdings at 75 EUR/ share.

Read more

How to invest into Venture Capital part 2: Augmentum, Vostok & others

Posted on by 13 comments

This is the follow-up on part 1 some days ago.. These were the listed VC vehicles,I presented as the base in part 1 (in brackets my short vote for the first 4)

  • Softbank (too crazy)
  • Kinnevik (Yes)
  • Rocket Internet (bad rep)
  • German Startup Group (no thanks)
  • Vostok New Ventures
  • Vostok Emerging Finance
  • Augmentum

I have added two US vehicles to this list:

  • Firsthand Technology Value Fund (SVVC)
  • GSV Capital (GSVC)

A few thoughts on Permanent Capital vs. “classical” fund structure vs. “SPACs”

In the previous post, one commentator mentioned that he was “sceptical of permanent capital” vehicles. Personally I would not support this. Berkshire Hathaway for instance is a permanent investment vehicle with quite some success. However there are other vehicles like Greenlight Re or Bill Ackman’s Persing NV which clearly have done a lousy job for shareholders as we can see in this chart: (Greenlight in yellow, Pershing Square blue):

greenlight pershing

Read more

Another return of the Watch Series: FitBit (FIT) – dead horse or exciting pivot ?

Posted on by 6 comments

Watches again…..

Although I wrote a lot about Watch companies over the past few years (Swatch part 1, Swatch part 2, Hengdeli, Fossil part 1, Fossil part 2, Movado, Richemont), no investment came out of it. However I had a lot of fun researching these companies so it was time well spent.

When I initiated the series in 3 years ago, Smart Watches were a big thing and especially the Apple Watch was perceived to be the “Swiss Watch” killer, which, as we know now didn’t happen as they seem to coexist quite well.

Besides Smart Watches, Fitness Trackers were the “hot shit” and especially VC backed FitBit that IPOed in 2015 was taking oer the world.

This chart shows Fitbit against Fossil (blue)  and Richemont (green) and we can clearly see who had staying power and who not:

Read more

Saga PLC (ISIN GB00BLT1Y088) – High Quality Travel / Insurance Hybrid ?

Posted on by 7 comments

The company:

Saga Plc is a UK company that combines two business that I have looked at quite often: Insurance and Travel.

Saga has its origin as a Seaside Hotel in England and then became a travel company before then moving into insurance in the 1980s. Saga caters specifically for the “over 50” market and claims to be the “leading provider” to people over 50 in the uK.

After a PE financed management buyout in 2007, he company was IPOed in May 2014 at a price of 185 pence / share.

Looking at the stock chart, IPO investors at first saw a decent outperformance before things went south this year:

Read more

Boiron SA (ISIN FR0000061129) – Boring enough to invest ?

Posted on by 23 comments

It’s no secret that I like French family run companies. TFF Group, G. Perrier, Installux, Dom Security are just the main examples of these kind of companies.

boironlogo_notag_blue

Boiron SA is a French company which Bloomberg lists as “Specialty Pharmaceutical” company. Although “Specialty Pharma” is not exactly what they do. in fact, Boiron SA ist the only listed company that I know that exclusively produces and sells Homeopathic “pharmaceutical” products. The call themselves “World leader” of this field.

A few words on Homeopathy

From Wikipedia:

Read more

Kinnevik AB – Better than Buffett, Watsa, Wallenberg & Co ?

Posted on by 25 comments

kinnevik_logo

Kinnevik is one of the more well-known “typical” Swedish investment companies. Founded in 1936 and still controlled (via A shares with multiple votes) by the 3 founding families, Stenbeck, Van Horn and Klingspor, the company now has a market cap of around 7,8 bn EUR.

Originally, farming, forestry & industrial were their main businesses but Jan Hugo Stenbeck, who unfortunately died in 2002 at the age of 59, transformed Kinnevik into a more “modern” company.

One specific feature of Stenbeck was that he didn’t only invest in listed companies but also helped to create new companies or invested in a very early stages. This is from Stenbeck’s obituary in the annual report 2002:

Read more

Record Plc (ISIN GB00B28ZPS36) – I like that record too !!!

Posted on by 34 comments

Disclaimer: This is not investment advice. PLEASE DO YOUR OWN RESEARCH !!!

logo_shadow

A few months ago, fellow blogger Wexboy had a very interesting post on Record Plc, a UK based “specialty asset manager”. Go and read the whole thing, it is worth it.

I try to summarize the business & background  in my own words:

Record Plc provides so-called “Currency overlay” asset management services. Currency overlays are in principle used for two reasons.

  1. To hedge an international investment portfolio into one single currency, usually the currency of the investor and/or
  2. To gain some extra yield by hedging currency exposures more “dynamically”

It is important to know that they do not manage the underlying assets, but “just” a derivative portfolio hedging the underlying assets and that they do not use their own balance sheet but act solely as an agent for the ultimate client.

Read more

« Older Entries